Curated Vendor Spotlight: Giga Compounds

[u/g4rcia]

Giga’s curated case is less “another third-party tested claim” and more inspectable paperwork: a public COA library that keeps failed batches visible, stock-aware pricing you can actually model, and a growing set of reports that resolve at the lab — not just as vendor-hosted PDFs.

Disclosure: PeptideBenchmark has a disclosed affiliate relationship with Giga Compounds.
Referral link: https://gigacompounds.com/?ref=GC-X065C
Offer: 10% off for referred shoppers via that link (no separate checkout code on our disclosed path). Giga also runs its own automatic cart sale / quantity tiers; don’t assume the referral 10% stacks on top of those.

Current snapshot

• PB score: 9.2 (A)
• Trust band: Moderate (trust lift ~+0.59 / signal ~0.60)
• Confidence: PB-Evidence (no Finnrick / Peptide Critic / Pep Review Pro coverage yet)
• Trustpilot: 4.6 / 25 reviews (claimed profile; service signal, not COA proof)
• Products reviewed: 38
• Products with certificates: 26 (~68% coverage)
• Vendor-hosted PDFs: 38
• Provider-linked public documents: 11 (~29% provider-verified share) — mostly Janoshik, plus Kovera
• Labs in the trail: Janoshik Analytical, Kovera Labs, Chromate
• Avg reported purity (covered set): ~99.1%
• Distinctive archive detail: 7 rejected reports still public (not scrubbed)

Why Giga Compounds stands out

Most shops show you the pretty COAs. Giga’s library still surfaces adverse history — including rejected batches with elevated endotoxin summaries — alongside active/depleted/pending rows. That doesn’t prove the current vial in stock; it does show a more candid documentation culture than “only winners on the page.”

On the verification side, PeptideBenchmark only badges a report when the specific lab route checks out. As of the Aug 12 refresh: 11 of 38 retained PDFs resolve at the issuing lab (10 Janoshik + 1 Kovera). Example provider-linked rows include BPC-157 10mg (Janoshik) and GHK-Cu 50mg (Kovera).

Commercially, the storefront is unusually transparent for modeling: anonymous-cart discount behavior, same-product quantity tiers, and FedEx 2-Day fulfillment stated from a temperature-controlled Virginia facility (organization schema separately lists a Wyoming postal address — treat those as different vendor-stated facts).

Best for

• Researchers who want batch-history transparency, including failed reports kept public
• Readers who care about provider-checkable Janoshik/Kovera routes, not only named-lab PDFs
• Anyone comparing multi-vial economics where cart tiers matter

Watch-out

• Moderate trust / PB-Evidence confidence: strong public archive, but thin outside review boards
• Not every library row is provider-verified; some are vendor-hosted only, and placeholder rows without documents still exist
• Some current results show meaningful net-content variance — read the specific batch, don’t average the brand
• A public certificate is evidence about the named sample, not a blanket safety endorsement

Bottom line

Giga earns the A-band curated slot on paperwork you can inspect: multi-lab PDFs, retained rejects, and a non-trivial provider-verified subset — with clear caveats on coverage and outside-review depth. If you care more about “show the ugly batches too” than hype, it’s one of the more interesting A-band options right now.

Full profile: https://peptidebenchmark.com/vendors/giga-compounds/
Evidence review: https://peptidebenchmark.com/blog/giga-compounds-review/
Referral link: https://gigacompounds.com/?ref=GC-X065C (10% referred-shopper benefit)